Preventing Substance Use in the Context of Poverty: Risk and Protection from Early Childhood to Early Adulthood

Abstract: The COVID-19 pandemic has impacted the lives and well-being of people across the world. In the UnitedStates, different states have adopted different measures to limit the spread of COVID-19, but the impact of aslowed economy, increased social isolation, and the loss of typically-available support services hasdisproportionally affected racial and ethnic minorities, as well as those in disadvantaged socioeconomicgroups. Tobacco, marijuana, alcohol, opioid, and illicit drug users are likely vulnerable to COVID-19 because ofthe effects of those substances on the respiratory and immune systems, and people who are in treatment orrecovery from substance misuse may be at risk for relapse because of increased mental health issues andadditional barriers to obtaining treatment and support. There are indications that substance use has increasedbecause of the pandemic, but rigorous prospective studies have yet to be conducted. The Early Steps MultisiteStudy of diverse lower income families, recruited from three geographic areas across the country(Pennsylvania, Virginia, and Oregon), presents unique research opportunities during this pandemic. There is awealth of data available on the Early Steps participants, including the history of substance use, social andhealth service utilization, and mental health of both primary caregiving adults (current Mage = 43.8; SD = 7.4)and youth (current Mage = 18.6; SD = 0.5). As the study design also included a randomized control trial of theFamily Check-Up intervention, we can also test the potential protective effects of the intervention on COVID-19related outcomes. We plan to administer two COVID-19 related surveys to Early Steps participants, at both 6months post-COVID-19 (September of 2020) and at 12 months post-COVID-19 (March of 2021). Our first aimis to examine the effects of the COVID-19 pandemic on substance use, mental health, and service utilization(i.e., addiction treatment, access to health care) in both caregiving adults and their young adult children. Weplan to test the extent to which a history of mental health problems among parents and young adultsmoderates the effects of COVID-19 on their substance use, and to test the extent to which service utilization atthe 6-month assessment mediates the effects of COVID-19 on substance use at the 12-month assessment inadult caregivers and young adult children. We will examine differences by geographic location, race/ethnicity,biological sex, and income. We hypothesize that those with more service utilization at 6 months post-COVID-19 will have less substance use at 12 months post-COVID-19. Our second aim is to examine the potentialbuffering effects of the Family Check-Up on substance use and mental health outcomes 6 and 12 monthsfollowing the onset of COVID-19, with those families randomly assigned to the intervention expected to showlower levels of substance use, mental health problems, and greater service utilization. We also will examinemoderators of potential FCU protective effects, including child, family, and community risk factors. These datacan begin to illuminate the wide-ranging impact of COVID-19 on vulnerable populations.